2-萘胺,91-59-8，生产厂家，价格-洛克化工网移动版

返回



首页
客服小蜜
会员中心

基本信息

制备方法及用途

物化性质

安全信息

毒理性

MSDS

海关数据

结构与计算化学

上游产品

下游产品

表征图谱

2-萘胺

中文名称：: 2-萘胺

中文别名：: 2-萘胺;
2-氨基萘;
β-Naphthylamine;
β-萘胺;
萘-2-胺;
乙-萘胺

英文名称：: 2-Naphthalenamine

英文别名：: 2-naphthylamine;
2-Naftylamin;
USAF CB-22;
naphthalen-2-ylamine;
naphthalene-2-amine;
2-Aminonaphthalene;
2-Naftylamine;
2-Naphthylamine;
2-amino-naphthalene

CAS No.：: 91-59-8

分子式：: C₁₀H₉N

分子量：: 143.19

精确分子量：: 143.07300

PSA：: 26.02000

MDL：: MFCD00004112

EINECS：: 202-080-4

BRN：: 606264

InChI：: InChI=1/C10H9N/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,11H23

危险品标志：: TN

风险术语：: R45;R22;R51/53

安全术语：: S53;S45;S61

分子结构式：

SDS：: 查看

2-萘胺制备方法及用途

制备方法

将20%氨水,亚硫酸铵和2-萘酚加入高压釜内,搅拌加热到150～155oC,反应8h,压力约为1MPa。所得反应物用水洗涤,加热溶于稀盐酸中,趁热过滤。滤液于50oC用氢氧化钠或碳酸钠溶液碱化,析出的细小结晶物用温水洗涤,干燥即得成品。

合成制备方法

将20%氨水，亚硫酸铵和2-萘酚加入高压釜内，搅拌加热到150～155ºC，反应8h,压力约为1MPa。所得反应物用水洗涤，加热溶于稀盐酸中，趁热过滤。滤液于50ºC用氢氧化钠或碳酸钠溶液碱化，析出的细小结晶物用温水洗涤，干燥即得成品。

用途简介

1.萘胺的氨基与亚硝酸作用形成重氮盐,并可转烃成多种萘的衍生物,用于制造染料和有机合成,也用作有机分析试剂和荧光指标剂。 2.用作染料中间体、分析试剂。

用途

1.萘胺的氨基与亚硝酸作用形成重氮盐，并可转烃成多种萘的衍生物，用于制造染料和有机合成，也用作有机分析试剂和荧光指标剂。

2.用作染料中间体、分析试剂。^[22]

2-萘胺物化性质

外观与性状：: 黄色粉末
密度：: 1.061 g/mL at 25 °C(lit.)
熔点：: 111-113 °C(lit.)
沸点：: 306 °C(lit.)
闪点：: 157.1ºC
水溶解性：: <0.1 g/100 mL at 22℃
折射率：: 1.6493 (98ºC)
存储条件/存储方法：: 库房通风低温干燥,与酸类、氧化剂、食品添加剂分开存放
稳定性相关：: 1.稳定性^[17] 稳定
2.禁配物^[18] 强氧化剂、酸类、酸酐
3.聚合危害^[19] 不聚合
4.分解产物^[20] 氨
其它信息：: 1.性状：白色至微粉红色片状，略有芳香气味。^[1]
2.熔点（℃）：111~113^[2]
3.沸点（℃）：306.0^[3]
4.相对密度（水=1）：1.06（98℃）^[4]
5.相对蒸气密度（空气=1）：4.95^[5]
6.饱和蒸气压（kPa）：0.13（108.0℃）^[6]
7.燃烧热（kJ/mol）：-5270.9^[7]
8.辛醇/水分配系数：2.28^[8]
9.闪点（℃）：157^[9]
10.溶解性：溶于热水、乙醇、乙醚、苯及多种有机溶剂。^[10]

2-萘胺安全信息

包装等级：: II
风险类别：: 6.1(a)
海关代码：: 2921450010
WGK_Germany：: 3
德国有关水污染物质的分类清单
危险类别码：: R45;R22;R51/53
安全说明：: S53-S45-S61
RTECS号：: QM2100000
安全标志：: S45:出现意外或者感到不适，立刻到医生那里寻求帮助（最好带去产品容器标签）。
S53:避免暴露——使用前先阅读专门的说明。
S61:避免排放到环境中。参考专门的说明/安全数据表。
危险标志：: T:Toxic;N:Dangerousfortheenvironment;

2-萘胺毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :: QM2100000

CHEMICAL NAME :: 2-Naphthylamine

CAS REGISTRY NUMBER :: 91-59-8

LAST UPDATED :: 199712

DATA ITEMS CITED :: 119

MOLECULAR FORMULA :: C10-H9-N

MOLECULAR WEIGHT :: 143.20

WISWESSER LINE NOTATION :: L66J CZ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 727 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 200 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

TYPE OF TEST :: LDLo - Lowest published lethal dose

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 500 mg/kg

TOXIC EFFECTS :: Lungs, Thorax, or Respiration - cyanosis Kidney, Ureter, Bladder - hematuria Blood - methemoglobinemia-carboxyhemoglobin

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 17100 mg/kg/57W-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1300 mg/kg/13W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - lymphoma, including Hodgkin's disease Tumorigenic - tumors at site of application

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 6 gm/kg/60W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - lymphoma, including Hodgkin's disease Tumorigenic - tumors at site of application

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 600 mg/kg/8W-I

TOXIC EFFECTS :: Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1500 mg/kg/8W-I

TOXIC EFFECTS :: Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1600 mg/kg/40W-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Parenteral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 18 mg/kg

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Lungs, Thorax, or Respiration - tumors Blood - lymphoma, including Hodgkin's disease

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Implant

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 100 mg/kg

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 18 gm/kg/2Y-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Unreported

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 40 gm/kg/81W

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Multiple routes

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 3077 mg/kg/78W-C

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Primate - monkey

DOSE/DURATION :: 17 gm/kg/5Y-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 40 gm/kg/5Y

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - hamster

DOSE/DURATION :: 217 mg/kg/45W-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - hamster

DOSE/DURATION :: 365 gm/kg/43W-C

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 108 mg/kg/4Y

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 31 gm/kg/2Y

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 30 gm/kg/5Y

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Multiple routes

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 4379 mg/kg/80W-C

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 80 mg/kg

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 13 gm/kg/1Y-I

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Reproductive - Tumorigenic effects - testicular tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Multiple routes

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 5169 mg/kg/91W-C

TOXIC EFFECTS :: Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 16 gm/kg/52W-I

TOXIC EFFECTS :: Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Skin and Appendages - tumors

TYPE OF TEST :: TD - Toxic dose (other than lowest)

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Mammal - dog

DOSE/DURATION :: 94500 mg/kg/9Y-I

TOXIC EFFECTS :: Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors

TYPE OF TEST :: Specific locus test

TYPE OF TEST :: Micronucleus test

TYPE OF TEST :: Cytogenetic analysis

TYPE OF TEST :: Morphological transformation

TYPE OF TEST :: DNA damage

TYPE OF TEST :: Cytogenetic analysis

TYPE OF TEST :: Micronucleus test

TYPE OF TEST :: Micronucleus test

TYPE OF TEST :: Specific locus test

TYPE OF TEST :: DNA inhibition

TYPE OF TEST :: Sister chromatid exchange

TYPE OF TEST :: DNA adduct

TYPE OF TEST :: DNA adduct

MUTATION DATA

TYPE OF TEST :: DNA damage

TEST SYSTEM :: Mammal - species unspecified Lymphocyte

REFERENCE :: MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 368,235,1996 *** REVIEWS *** ACGIH TLV-Confirmed human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Human Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 4,97,1974 IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 4,97,1974 IARC Cancer Review:Group 1 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,261,1987 TOXICOLOGY REVIEW KHZHAZ Khimiya i Zhizn. Chemistry and Life. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1965- Volume(issue)/page/year: 12(2),85,1976 TOXICOLOGY REVIEW ADCSAJ Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- Volume(issue)/page/year: 13,271,1970 TOXICOLOGY REVIEW BLFSBY Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- Volume(issue)/page/year: 24,253,1983 *** U.S. STANDARDS AND REGULATIONS *** OSHA PEL (Construc):see CFR 29,1926.1109 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA-cancer suspect agent CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1009,1987 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA;Carcinogen JAN 1993 OEL-BELGIUM;Carcinogen JAN 1993 OEL-FINLAND;Carcinogen JAN 1993 OEL-FRANCE:TWA 0.001 ppm (0.005 mg/m3);Carcinogen JAN 1993 OEL-FRANCE;Carcinogen JAN 1993 OEL-GERMANY;Skin;Carcinogen JAN 1993 OEL-SWEDEN;Carcinogen JAN 1993 OEL-SWITZERLAND;Skin;Carcinogen JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO beta-NAPHTHYLAMINE-air:CA use 29 CFR 1910.1009 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 50065 No. of Facilities: 10 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 420 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 50065 No. of Facilities: 10 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 275 (estimated) No. of Female Employees: 265 (estimated)

毒理学数据：

1.急性毒性^[11] LD50：727mg/kg（大鼠经口）

2.刺激性 暂无资料

3.致突变性^[12] 微生物致突变：鼠伤寒沙门菌2μg/皿。DNA损伤：人成纤维细胞50μmol/L。程序外DNA合成：800μg/L。DNA抑制：人Hela细胞200μmol/L。

4.致癌性^[13] IARC致癌性评论：G1，确认人类致癌物。

生态数据：

1.生态毒性 暂无资料

2.生物降解性^[14]

好氧生物降解（h）：672~4320

厌氧生物降解（h）：2880~17280

3.非生物降解性^[15]

水中光氧化半衰期（h）：62~3480

空气中光氧化半衰期（h）：0.3~2.9

4.其他有害作用^[16] 该物质对环境有危害，特备注意对水体的污染。

2-萘胺 MSDS

国标编号:	61830
ＣＡＳ:	91-59-8
中文名称:	2-萘胺
英文名称:	β-Naphthylamine；β-Aminonaphthaalene
别名:	β-萘胺；β-氨基萘
分子式:	C₁₀H₉N；C₁₀H₇NH₂
分子量:	143.18
熔点:	111.5℃
密度:	相对密度(水=1)1.06
蒸汽压:	>110℃
溶解性:	溶于热水、乙醇、乙醚、苯
稳定性:	稳定
外观与性状:	白色到微粉红色片状，略有芳香气味
危险标记:	15(毒害品)
用途:	用作染料中间体，分析试剂

2.对环境的影响: 一、健康危害侵入途径：吸入、食入、经皮吸收。健康危害：有形成高铁血红蛋白血症的作用。中毒症状有紫绀和排尿困难等。二、毒理学资料及环境行为急性毒性：LD50727mg/kg(大鼠经口) 致突变性：微粒体致突变：鼠伤寒沙门氏菌10ug/皿。微生物致突变：枯草菌5g/L。致癌性：IARC致癌性评论：人为可疑性反应，动物为不肯定反应。危险特性：遇明火、高热或与氧化剂接触，有引起燃烧的危险。受高热分解放出有毒的气体。燃烧(分解)产物：一氧化碳、二氧化碳、氧化氮。 3.现场应急监测方法: 　 4.实验室监测方法: 色谱/质谱法《固体废弃物试验分析评价手册》中国环境监测总站等译空气中的测定：样品用装硅胶的玻璃纤维过滤器收集，用醋酸丙醇溶液洗脱，再用气相色谱法分析(NIOSH法) 5.环境标准: 前苏联规定不允许在空气中有β-萘胺的存在，在生产中也不允许工人直接与β-萘胺接触空气中嗅觉阈浓度 0.24～0.32ppm 6.应急处理处置方法: 一、泄漏应急处理隔离泄漏污染区，周围设警告标志，建议应急处理人员戴好防毒面具，穿化学防护服。不要直接接触泄漏物。用沙土、干燥石灰或苏打灰混合，然后避免扬尘，小心扫起，置于袋中转移至安全场所。如大量泄漏，收集回收或无害处理后废弃。废弃物处置方法：建议用控制焚烧法处置。焚烧炉排出的氮氧化物通过洗涤器或催化氧化装置除去。二、防护措施呼吸系统防护：空气中浓度超标时，应该佩带防毒口罩。紧急事态抢救或逃生时，议佩戴自给式呼吸器。眼睛防护：可采用安全面罩。防护服：穿相应的防护服。手防护：必要时戴防化学品手套。其它：工作现场禁止吸烟、进食和饮水。工作后，彻底清洗。单独存放被毒物污染的衣服，洗后再用。注意个人清洁卫生。三、急救措施皮肤接触：脱去污染的衣着，用肥皂水及清水彻底冲洗。眼睛接触：立即提起眼睑，用大量流动清水或生理盐水冲洗。吸入：迅速脱离现场至空气新鲜处。必要时进行人工呼吸。就医。食入：误服者给漱口，饮水，洗胃后口服活性炭，再给以导泻。就医。灭火方法：雾状水、二氧化碳、砂土、泡沫。

2-萘胺海关数据

中国海关编码：2921450010

概述：: HS:2921450010 2-萘胺增值税率:17.0% 退税率:9.0% 监管条件:X 最低关税:6.5% 普通关税:30.0%
申报要素：: 品名, 成分含量, 用途
监管条件：: X.有毒化学品环境管理放行通知单
摘要/Summary：: HS:2921450010 naphthalen-2-amine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:x MFN tariff:6.5% General tariff:30.0%

2-萘胺分子结构与计算化学数据

分子结构数据

1、摩尔折射率：48.33

2、摩尔体积（cm³/mol）：125.8

3、等张比容（90.2K）：336.9

4、表面张力（dyne/cm）：51.4

5、介电常数：无可用的

6、极化率（10^-24cm³）：19.16

7、单一同位素质量：143.073499 Da

8、标称质量：143 Da

9、平均质量：143.1852 Da

计算化学数据

1.疏水参数计算参考值（XlogP）:无

2.氢键供体数量:1

3.氢键受体数量:1

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积26

7.重原子数量:11

8.表面电荷:0

9.复杂度:133

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

2-萘胺上游产品

2-溴代萘 2-萘甲酸 2-萘硼酸 2-萘基三氟甲烷磺酸

2-萘胺下游产品

2,2-二萘胺 N-乙醯萘胺液氨色酚AS-SW

2-萘胺表征图谱

2-萘胺质谱(MS)

武汉吉鑫益邦生物科技有限公司

2-萘胺

联系人：周美玲
电话：027-59768650
手机：15629090339

Cas号：91-59-8
包装：1kg,25kg,200kg,400kg,500kg
纯度：0-99%
价格：洽谈

2-萘胺

2-萘胺 制备方法及用途

制备方法

合成制备方法

用途简介

用途

2-萘胺 物化性质

2-萘胺 安全信息

2-萘胺 毒理性

CHEMICAL IDENTIFICATION

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

2-萘胺 MSDS

2-萘胺 海关数据

中国海关编码：2921450010

2-萘胺 分子结构与计算化学数据

分子结构数据

计算化学数据

2-萘胺 上游产品

2-萘胺 下游产品

2-萘胺 表征图谱

推荐供应商

武汉吉鑫益邦生物科技有限公司

2-萘胺

2-萘胺制备方法及用途

2-萘胺物化性质

2-萘胺安全信息

2-萘胺毒理性

2-萘胺海关数据

2-萘胺分子结构与计算化学数据

2-萘胺上游产品

2-萘胺下游产品

2-萘胺表征图谱